Search For "oxford"
Oxford COVID-19 vaccine's phase two trial begins at Pune hospital
Updated : 5 years, 6 months ago IST
Pune (Maharashtra) [India], Aug 26 (ANI): The second phase trial of COVID-19 vaccine developed by Oxford University, which would be manufactured by Serum Institute of India, began here with the vaccine candidate administered to two volunteers at Bharati Vidyapeeth Medical College.
Read More
Researchers find new potential treatment for prion diseases
Updated : 5 years, 7 months ago IST
Washington D.C. [USA], Aug 15 (ANI): A novel study has suggested a possible effective treatment strategy for patients suffering from prion disease. The study has been published by Oxford University Press.
Read More
Researchers find new potential treatment for prion diseases
Updated : 5 years, 7 months ago IST
Washington D.C. [USA], Aug 10 (ANI): A possible effective treatment strategy for patients suffering from prion disease, has been suggested by a novel study published by the Oxford University Press.
Read More
DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine tria
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 3 (ANI): The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India, said the Ministry of Health and Family Welfare on
Read More
Wockhardt announces Covid-19 vaccine partnership with UK government
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 3 (ANI): Pharmaceutical and biotechnology major Wockhardt said on Monday it has entered into an agreement with the UK Government to fill-finish Covid-19 vaccines.
Read More
DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in
Updated : 5 years, 7 months ago IST
New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine, a senior government official said.
Read More
Drug regulator gets committee approval for nod to clinical trials by Serum
Updated : 5 years, 7 months ago IST
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Read More
COVID-19 vaccine development: Only 3 vaccine candidates in phase III acros
Updated : 5 years, 7 months ago IST
New Delhi [India], July 30 (ANI): In the development related to the COVID-19 vaccine across the world, only three vaccine candidates are in phase III clinical trials across the globe. These three coronavirus vaccine candidates are from the USA, UK (University of Oxford's vaccine) and Chin
Read More
Drug Regulator asks Serum Institute to furnish revised protocol for COVID-
Updated : 5 years, 7 months ago IST
New Delhi [India], July 29 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has advised the Serum Institute of India (SII) to submit a revised protocol to perform the clinical trials in India for potential COVID-19 vaccine.
Read More
Domestic pharma giant SII applies to DCGI for phase 2/3 clinical trial of
Updated : 5 years, 7 months ago IST
New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) for conducting the Phase 2/3 human clinical trials for a potential coronavirus vaccine.
Read More
Odisha CM seeks Serum Institute CEO's cooperation for early COVID-19 vacci
Updated : 5 years, 7 months ago IST
Bhubaneswar (Odisha) [India], July 22 (ANI): Odisha Chief Minister Naveen Patnaik on Wednesday spoke to Adar Poonawalla, CEO of Serum Institute over a video call to discuss on the progress of coronavirus vaccine.
Read More
Oxford's coronavirus vaccine 'safe, immunogenic': Study
Updated : 5 years, 7 months ago IST
London [UK], July 20 (ANI): A vaccine candidate developed at the University of Oxford has shown encouraging results in early human testing and appears to be "safe well-tolerated, and immunogenic", according to a study published in The Lancet.
Read More